| Mr Richard Anthony Palmer, MD | |
|
1122 14th Ave Se, Decatur, AL 35601-3361 | |
| (256) 764-9697 | |
| (256) 552-3990 |
| Full Name | Mr Richard Anthony Palmer |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 1122 14th Ave Se, Decatur, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962639997 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Decatur Morgan Hospital - Decatur Campus | Decatur, AL | Hospital |
| Huntsville Hospital | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Services Of Decatur, P.c. | 4183618226 | 10 |
News Archive
The patient and caregiver-centered Aging Brain Care program, developed by researchers at the Regenstrief Institute and the Indiana University Center for Aging Research, is attracting nationwide interest for its ability to improve health outcomes and quality of care for those with cognitive impairment while dramatically lowering costs to patients and health care systems.
People from around the country and the world turn to Johan Van Hove, MD, PhD, for advice on a rare metabolic disease known as NKH, which can disrupt the body in devastating and even deadly ways. Now, Van Hove, a University of Colorado medical school professor, has identified a new disease related to NKH, a finding that resolves previously baffling cases including the death of a Colorado girl.
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
As provinces across Canada are deciding how to restart schools during the pandemic, a research review has found children are not a major source of transmission of COVID-19.
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
› Verified 7 days ago
| Entity Name | Anesthesia Services Of Decatur, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629034624 PECOS PAC ID: 4183618226 Enrollment ID: O20040412001701 |
News Archive
The patient and caregiver-centered Aging Brain Care program, developed by researchers at the Regenstrief Institute and the Indiana University Center for Aging Research, is attracting nationwide interest for its ability to improve health outcomes and quality of care for those with cognitive impairment while dramatically lowering costs to patients and health care systems.
People from around the country and the world turn to Johan Van Hove, MD, PhD, for advice on a rare metabolic disease known as NKH, which can disrupt the body in devastating and even deadly ways. Now, Van Hove, a University of Colorado medical school professor, has identified a new disease related to NKH, a finding that resolves previously baffling cases including the death of a Colorado girl.
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
As provinces across Canada are deciding how to restart schools during the pandemic, a research review has found children are not a major source of transmission of COVID-19.
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Richard Anthony Palmer, MD 1122 14th Ave Se, Decatur, AL 35601-3361 Ph: (256) 764-9697 | Mr Richard Anthony Palmer, MD 1122 14th Ave Se, Decatur, AL 35601-3361 Ph: (256) 764-9697 |
News Archive
The patient and caregiver-centered Aging Brain Care program, developed by researchers at the Regenstrief Institute and the Indiana University Center for Aging Research, is attracting nationwide interest for its ability to improve health outcomes and quality of care for those with cognitive impairment while dramatically lowering costs to patients and health care systems.
People from around the country and the world turn to Johan Van Hove, MD, PhD, for advice on a rare metabolic disease known as NKH, which can disrupt the body in devastating and even deadly ways. Now, Van Hove, a University of Colorado medical school professor, has identified a new disease related to NKH, a finding that resolves previously baffling cases including the death of a Colorado girl.
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
As provinces across Canada are deciding how to restart schools during the pandemic, a research review has found children are not a major source of transmission of COVID-19.
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
› Verified 7 days ago
Dr. Loyd E. Shaw, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2000 Fax: 256-350-2609 | |
Dr. George C. Faison, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-973-2000 Fax: 256-350-2609 | |
Mark A Murphy, M.D Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1852 Beltline Rd Sw, Suite G, Decatur, AL 35601 Phone: 256-340-9553 Fax: 256-340-9895 | |
Dr. David E. Tyler, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2000 Fax: 256-350-2609 | |
Dr. Naga Raju Danthuluri, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2828 Highway 31 S, Decatur, AL 35603 Phone: 256-340-1212 | |
Mr. Charles Langdon Watkins, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1704 Summerlane Se, Decatur, AL 35601 Phone: 256-353-4073 | |
Dr. Charles J. Mccollum, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2000 Fax: 256-350-2609 |